Daniel E. Furst, MD

Daniel E. Furst, MD is Professor of Medicine at the University of California (emeritus), Los Angeles (UCLA), Medical Center, David Geffen School of Medicine, Department of Medicine, Division of Rheumatology. He is also Adjunct Professor at the University of Washington, Seattle Washington and Research Professor at the University of Florence, Florence, Italy.

Dr. Furst received his MD from Johns Hopkins University, where he also completed his internship and residency. He completed two fellowships, one in Rheumatology at UCLA Medical Center, and a second in clinical pharmacology at the University of California, San Francisco Medical Center.

After serving as assistant professor of medicine/rheumatology at the UCLA Medical Center and associate professor of internal medicine/Rheumatology at the University of Iowa Carver College of Medicine, Dr. Furst became clinical professor in the Department of Medicine, Division of Rheumatology and Connective Tissue Research at the University of Medicine and Dentistry of New Jersey, and director of AI/P Clinical Research at Ciba Geigy Pharmaceuticals. He subsequently was clinical professor of medicine at the University of Washington, then director of clinical research programs and director of the Arthritis Clinical Research Unit at the Virginia Mason Medical Center. He moved to UCLA in 2002 and became emeritus in 2015. At that time, he took on his several other positions and practices.

Dr. Furst’s research interests center on the clinical pharmacology of antirheumatic drugs and biologics and on the pathophysiology and treatment of progressive systemic sclerosis. He is on the national medical advisory board of the Scleroderma Foundation, the scientific advisory board of the Arthritis Foundation, and the board of directors for the foundation of the Collaboration of Research Rheumatologists of North America. He is a prolific author and an active editor for multiple publications.